Monday, January 23, 2017

BRIEF-Vistagen Therapeutics files for mixed shelf of up to $100 million

* Files for mixed shelf of up to $100 million - SEC filing

Source text for Eikon:

Further company coverage:

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)